JP2020534277A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534277A5 JP2020534277A5 JP2020515175A JP2020515175A JP2020534277A5 JP 2020534277 A5 JP2020534277 A5 JP 2020534277A5 JP 2020515175 A JP2020515175 A JP 2020515175A JP 2020515175 A JP2020515175 A JP 2020515175A JP 2020534277 A5 JP2020534277 A5 JP 2020534277A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- polypeptide
- acid sequence
- isolated antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023136384A JP2023163183A (ja) | 2017-09-14 | 2023-08-24 | 抗trem2抗体及びその使用方法 |
| JP2025113952A JP2025133893A (ja) | 2017-09-14 | 2025-07-04 | 抗trem2抗体及びその使用方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762558803P | 2017-09-14 | 2017-09-14 | |
| US62/558,803 | 2017-09-14 | ||
| US201762583379P | 2017-11-08 | 2017-11-08 | |
| US62/583,379 | 2017-11-08 | ||
| US201862621380P | 2018-01-24 | 2018-01-24 | |
| US62/621,380 | 2018-01-24 | ||
| PCT/US2018/051166 WO2019055841A1 (en) | 2017-09-14 | 2018-09-14 | ANTI-TREM2 ANTIBODIES AND METHODS OF USE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023136384A Division JP2023163183A (ja) | 2017-09-14 | 2023-08-24 | 抗trem2抗体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020534277A JP2020534277A (ja) | 2020-11-26 |
| JP2020534277A5 true JP2020534277A5 (cg-RX-API-DMAC7.html) | 2021-10-14 |
| JP7403441B2 JP7403441B2 (ja) | 2023-12-22 |
Family
ID=63714159
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020515175A Active JP7403441B2 (ja) | 2017-09-14 | 2018-09-14 | 抗trem2抗体及びその使用方法 |
| JP2023136384A Pending JP2023163183A (ja) | 2017-09-14 | 2023-08-24 | 抗trem2抗体及びその使用方法 |
| JP2025113952A Pending JP2025133893A (ja) | 2017-09-14 | 2025-07-04 | 抗trem2抗体及びその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023136384A Pending JP2023163183A (ja) | 2017-09-14 | 2023-08-24 | 抗trem2抗体及びその使用方法 |
| JP2025113952A Pending JP2025133893A (ja) | 2017-09-14 | 2025-07-04 | 抗trem2抗体及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200277373A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3681909A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7403441B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111448212A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3075285A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019055841A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201790342A1 (ru) | 2014-08-08 | 2017-07-31 | ЭЛЕКТОР ЭлЭлСи | Антитела к trem2 и способы их применения |
| KR20240056629A (ko) | 2014-09-28 | 2024-04-30 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 자극성 및 비자극성 골수성 세포의 조절 |
| RS63818B1 (sr) | 2017-02-17 | 2023-01-31 | Denali Therapeutics Inc | Konstruisani polipeptidi za vezivanje za receptor transferina |
| JOP20190248A1 (ar) | 2017-04-21 | 2019-10-20 | Amgen Inc | بروتينات ربط مولد ضد trem2 واستخداماته |
| HUE062436T2 (hu) | 2017-08-03 | 2023-11-28 | Alector Llc | Anti-trem2 antitestek és alkalmazási módszereik |
| MX2020006213A (es) | 2017-12-12 | 2020-09-14 | Pionyr Immunotherapeutics Inc | Anticuerpos anti-trem2 y metodos relacionados. |
| CA3109763A1 (en) * | 2018-08-16 | 2020-02-20 | Denali Therapeutics Inc. | Engineered bispecific proteins |
| UY38407A (es) | 2018-10-15 | 2020-05-29 | Novartis Ag | Anticuerpos estabilizadores de trem2 |
| CA3120875A1 (en) | 2018-12-11 | 2020-06-18 | Pionyr Immunotherapeutics, Inc. | Methods of using anti-trem2 antibodies |
| JP7543290B2 (ja) | 2019-02-20 | 2024-09-02 | デナリ セラピューティクス インコーポレイテッド | 抗trem2抗体及びその使用方法 |
| CN110511240B (zh) * | 2019-08-27 | 2022-03-08 | 南京医科大学 | 一种髓细胞触发受体2的内源性配体及其应用 |
| IL293018A (en) * | 2019-11-22 | 2022-07-01 | Lilly Co Eli | trem2 antibodies and their uses |
| CN115003699A (zh) | 2019-12-05 | 2022-09-02 | 艾利妥 | 抗trem2抗体的使用方法 |
| US20230265212A1 (en) * | 2019-12-19 | 2023-08-24 | Kevin S. EISENFRATS | Compositions and methods for oocyte-specific contraception |
| WO2021146256A1 (en) * | 2020-01-13 | 2021-07-22 | Denali Therapeutics Inc. | Anti-trem2 antibodies and methods of use thereof |
| US11124567B2 (en) * | 2020-01-13 | 2021-09-21 | Denali Therapeutics Inc. | Anti-TREM2 antibodies and methods of use thereof |
| CN115768794A (zh) | 2020-02-24 | 2023-03-07 | 艾利妥 | 抗trem2抗体的使用方法 |
| CA3172451A1 (en) | 2020-04-03 | 2021-10-07 | Robert Paul | Methods of use of anti-trem2 antibodies |
| CN111793131A (zh) * | 2020-05-11 | 2020-10-20 | 廊坊天光生物技术有限公司 | 一种用于检测血清中pf4含量的抗体对及其用途 |
| CN116323667A (zh) * | 2020-07-08 | 2023-06-23 | 拉法医疗股份有限公司 | 结合PSMA和γ-δT细胞受体的抗体 |
| CN114075284B (zh) * | 2020-08-17 | 2023-11-17 | 上海元宋生物技术有限公司 | Cd47结合分子及其用途 |
| WO2022045865A1 (ko) * | 2020-08-31 | 2022-03-03 | (주)메디톡스 | 항-vegf 육량체 항체, 및 이를 포함하는 조성물 |
| US20240102094A1 (en) * | 2020-12-03 | 2024-03-28 | Amgen Inc. | Trem2 agonist biomarkers and methods of use thereof |
| CN112526143B (zh) * | 2020-12-03 | 2021-08-03 | 中山大学附属第五医院 | 髓系细胞触发受体2作为新型冠状病毒肺炎诊断或治疗靶点的应用 |
| WO2022241082A1 (en) | 2021-05-14 | 2022-11-17 | Genentech, Inc. | Agonists of trem2 |
| IL308804A (en) * | 2021-05-28 | 2024-01-01 | Vigil Neuroscience Inc | TREM2 agonistic biomarkers and methods of using them |
| CN115505041B (zh) * | 2021-06-22 | 2026-05-05 | 北京免疫方舟医药科技有限公司 | 抗EphA2抗体及其应用 |
| IL285416A (en) * | 2021-08-05 | 2023-03-01 | Yeda Res & Dev | Antibodies for cancer treatment |
| IL311003A (en) | 2021-08-25 | 2024-04-01 | Denali Therapeutics Inc | Anti-2HER antibodies and methods of using them |
| US20240392035A1 (en) * | 2021-08-25 | 2024-11-28 | Denali Therapeutics Inc. | Engineered anti-her2 bispecific proteins |
| WO2023039612A1 (en) * | 2021-09-13 | 2023-03-16 | The Board Of Regents Of The University Of Texas System | Trem2 antigen binding proteins and uses thereof |
| MX2024010324A (es) | 2022-02-23 | 2024-08-30 | Alector Llc | Metodos de uso de anticuerpos anti-trem2. |
| EP4499695A1 (en) | 2022-03-28 | 2025-02-05 | Denali Therapeutics Inc. | Methods for treating brain glucose hypometabolism |
| EP4499693A1 (en) | 2022-03-28 | 2025-02-05 | Denali Therapeutics Inc. | Monovalent anti-trem2 binding molecules and methods of use thereof |
| WO2023215697A1 (en) * | 2022-05-05 | 2023-11-09 | Eli Lilly And Company | Multispecific binding molecules and methods of use thereof |
| JP2025529287A (ja) | 2022-09-06 | 2025-09-04 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | マルファン症候群の処置のためのtrem-2アゴニスト |
| US20240262929A1 (en) * | 2023-02-06 | 2024-08-08 | Ibio, Inc. | Anti-muc16 antibodies |
| WO2024250809A1 (zh) * | 2023-06-08 | 2024-12-12 | 成都优洛生物科技有限公司 | 抗trem2全人源抗体或其抗原结合片段及其应用 |
| AU2024320793A1 (en) | 2023-08-09 | 2026-03-12 | F. Hoffmann-La Roche Ag | Mono and multispecific anti-trem2 antibodies, methods and uses thereof |
| AU2024323186A1 (en) | 2023-08-09 | 2026-01-15 | F. Hoffmann-La Roche Ag | Mono and multispecific anti-trem2 antibodies, methods and uses thereof |
| WO2025046298A2 (en) * | 2023-09-01 | 2025-03-06 | iTeos Belgium SA | Anti-trem2 antibodies and methods of use |
| CN117534569B (zh) * | 2023-11-23 | 2026-03-13 | 复旦大学附属华山医院 | S-9-pahsa在制备阿尔兹海默病及认知障碍疾病治疗药物中的用途 |
| CN118546252A (zh) * | 2024-04-02 | 2024-08-27 | 上海宏成药业有限公司 | 抗trem2抗体及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002021141A2 (en) | 2000-09-06 | 2002-03-14 | Aventis Pharma S.A. | Methods and compositions for diseases associated with amyloidosis |
| CN102268094A (zh) | 2002-08-30 | 2011-12-07 | 比奥雷克西斯药物公司 | 被修饰的转铁蛋白抗体的融合蛋白 |
| DK2046826T3 (da) | 2006-07-24 | 2011-10-24 | Biorexis Pharmaceutical Corp | Exendin-fusionsproteiner |
| TWI507525B (zh) * | 2009-06-26 | 2015-11-11 | Regeneron Pharma | 具天然免疫球蛋白形式之易分離的雙專一性抗體 |
| MX367126B (es) * | 2012-08-29 | 2019-08-06 | Hoffmann La Roche | Transporte para atravesar la barrera hematoencefálica. |
| EA201790342A1 (ru) | 2014-08-08 | 2017-07-31 | ЭЛЕКТОР ЭлЭлСи | Антитела к trem2 и способы их применения |
| WO2017058866A1 (en) * | 2015-09-28 | 2017-04-06 | Precision Immune, Inc. | Anti-trem2 antibodies and uses thereof |
| JP7725185B2 (ja) | 2015-10-06 | 2025-08-19 | アレクトル エルエルシー | 抗trem2抗体及びその使用方法 |
-
2018
- 2018-09-14 WO PCT/US2018/051166 patent/WO2019055841A1/en not_active Ceased
- 2018-09-14 US US16/646,536 patent/US20200277373A1/en not_active Abandoned
- 2018-09-14 EP EP18779998.6A patent/EP3681909A1/en active Pending
- 2018-09-14 CN CN201880069782.0A patent/CN111448212A/zh active Pending
- 2018-09-14 CA CA3075285A patent/CA3075285A1/en active Pending
- 2018-09-14 JP JP2020515175A patent/JP7403441B2/ja active Active
-
2023
- 2023-08-24 JP JP2023136384A patent/JP2023163183A/ja active Pending
-
2025
- 2025-07-04 JP JP2025113952A patent/JP2025133893A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7403441B2 (ja) | 抗trem2抗体及びその使用方法 | |
| JP7837375B2 (ja) | ピログルタメートアミロイド-βに対する抗体及びその使用 | |
| CA3190581A1 (en) | Treatment of diseases related to colony-stimulating factor 1 receptor dysfunction using trem2 agonists | |
| JP6210966B2 (ja) | 抗Siglec−15抗体 | |
| ES2619709T5 (es) | Agentes de unión a esclerostina | |
| ES3059612T3 (en) | Anti-alk2 antibody | |
| US20230012428A1 (en) | Bifunctional fusion protein and pharmaceutical use thereof | |
| JP2018531580A (ja) | 過リン酸化タウに特異的な抗体およびその使用方法 | |
| EP2832855A1 (en) | Novel anti-siglec15 antibody | |
| Von Büdingen et al. | Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce “oligoclonal bands” | |
| KR20140107493A (ko) | 항-phf-타우 항체 및 그의 용도 | |
| CA2724432A1 (en) | Compositions and methods for binding lysophosphatidic acid | |
| RS64386B1 (sr) | Anti-n3pglu amiloid beta peptid antitela i njihova upotreba | |
| JP2015057382A (ja) | 線維症、炎症性および新血管形成症状の処置および予防のための組成物および方法 | |
| RU2014118456A (ru) | Фосфоспецифичные антитела, распознающие тау | |
| JP2018508210A (ja) | タウに対する抗体およびその使用 | |
| JP2022526334A (ja) | 新たなタウ種を標的化することによるタウオパチー障害の処置の方法 | |
| CA3147020A1 (en) | Anti-nampt antibodies and uses thereof | |
| KR102385790B1 (ko) | 신규한 항-Fc-감마 수용체 IIB 항체 및 이의 용도 | |
| JP2025517356A (ja) | 抗cd22抗体オリゴヌクレオチドコンジュゲートを使用したがんの治療方法 | |
| US20140065154A1 (en) | Tlr3 binding agents | |
| TW202607018A (zh) | 抗載脂蛋白e4(apoe4)抗體及其用途 | |
| JP7520726B2 (ja) | 骨の疾患の治療に用いるためのトランスフェリン受容体2のアンタゴニスト及びアゴニスト | |
| US20250215077A1 (en) | Monovalent anti-trem2 binding molecules and methods of use thereof | |
| TW202535461A (zh) | 使用抗sirpa抗體治療肝臟疾病或病症 |